110 related articles for article (PubMed ID: 22159143)
21. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.
Zanzi D; Stefanile R; Santagata S; Iaffaldano L; Iaquinto G; Giardullo N; Lania G; Vigliano I; Vera AR; Ferrara K; Auricchio S; Troncone R; Mazzarella G
Am J Gastroenterol; 2011 Jul; 106(7):1308-17. PubMed ID: 21468011
[TBL] [Abstract][Full Text] [Related]
22. Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection.
Smyk-Pearson S; Golden-Mason L; Klarquist J; Burton JR; Tester IA; Wang CC; Culbertson N; Vandenbark AA; Rosen HR
J Infect Dis; 2008 Jan; 197(1):46-57. PubMed ID: 18171284
[TBL] [Abstract][Full Text] [Related]
23. CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs.
Mjösberg J; Berg G; Ernerudh J; Ekerfelt C
Immunology; 2007 Apr; 120(4):456-66. PubMed ID: 17229266
[TBL] [Abstract][Full Text] [Related]
24. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
[TBL] [Abstract][Full Text] [Related]
25. CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
Saresella M; Marventano I; Longhi R; Lissoni F; Trabattoni D; Mendozzi L; Caputo D; Clerici M
FASEB J; 2008 Oct; 22(10):3500-8. PubMed ID: 18587005
[TBL] [Abstract][Full Text] [Related]
26. Regulatory T cells in patients with Whipple's disease.
Schinnerling K; Moos V; Geelhaar A; Allers K; Loddenkemper C; Friebel J; Conrad K; Kühl AA; Erben U; Schneider T
J Immunol; 2011 Oct; 187(8):4061-7. PubMed ID: 21918190
[TBL] [Abstract][Full Text] [Related]
27. CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells.
Razmara M; Hilliard B; Ziarani AK; Chen YH; Tykocinski ML
Int Immunol; 2008 Apr; 20(4):471-83. PubMed ID: 18272926
[TBL] [Abstract][Full Text] [Related]
28. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells.
Schneider MA; Meingassner JG; Lipp M; Moore HD; Rot A
J Exp Med; 2007 Apr; 204(4):735-45. PubMed ID: 17371928
[TBL] [Abstract][Full Text] [Related]
29. Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype.
Taylor AL; Llewelyn MJ
J Immunol; 2010 Dec; 185(11):6591-8. PubMed ID: 21048104
[TBL] [Abstract][Full Text] [Related]
30. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation.
Siemasko KF; Gao J; Calder VL; Hanna R; Calonge M; Pflugfelder SC; Niederkorn JY; Stern ME
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5434-40. PubMed ID: 18658093
[TBL] [Abstract][Full Text] [Related]
31. Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.
Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; van Dam T; Ijzermans JN; Weimar W; Baan CC
Transplantation; 2010 Mar; 89(6):655-66. PubMed ID: 20164820
[TBL] [Abstract][Full Text] [Related]
32. CD4+ Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation.
Yurchenko E; Levings MK; Piccirillo CA
Eur J Immunol; 2011 Dec; 41(12):3455-66. PubMed ID: 21956668
[TBL] [Abstract][Full Text] [Related]
33. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients.
Masuda M; Matsumoto M; Tanaka S; Nakajima K; Yamada N; Ido N; Ohtsuka T; Nishida M; Hirano T; Utsumi H
J Neuroimmunol; 2010 Aug; 225(1-2):123-31. PubMed ID: 20472307
[TBL] [Abstract][Full Text] [Related]
34. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
Ye Z; Wang Y; Xie HY; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):608-14. PubMed ID: 19073406
[TBL] [Abstract][Full Text] [Related]
36. Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.
Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
Cancer Immunol Immunother; 2007 Sep; 56(9):1429-42. PubMed ID: 17265021
[TBL] [Abstract][Full Text] [Related]
37. HOZOTs, novel human regulatory T-cell lines, exhibit helper or suppressor activities depending on dendritic cell or anti-CD3 stimulation.
Sugimoto A; Suzuki M; Otani T; Okochi A; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2009 Dec; 37(12):1454-63. PubMed ID: 19819295
[TBL] [Abstract][Full Text] [Related]
38. Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.
Poggi A; Zocchi MR
Hum Immunol; 2008 Nov; 69(11):755-9. PubMed ID: 18817823
[TBL] [Abstract][Full Text] [Related]
39. The frequency of regulatory CD3+CD8+CD28- CD25+ T lymphocytes in human peripheral blood increases with age.
Simone R; Zicca A; Saverino D
J Leukoc Biol; 2008 Dec; 84(6):1454-61. PubMed ID: 18780874
[TBL] [Abstract][Full Text] [Related]
40. Allogeneic stimulation of naturally occurring CD4+CD25+ T cells induces strong regulatory capacity with increased donor-reactivity.
Coenen JJ; Koenen HJ; Emmer PM; van Rijssen E; Hilbrands LB; Joosten I
Transpl Immunol; 2007 Jun; 17(4):237-42. PubMed ID: 17493525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
